1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow EGFR Mutation: new trials by email Literature Review of EGFR Mutation trials Research Report on EGFR Mutation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2) BAY2927088_formulation A, BAY2927088_formulation B_1, BAY2927088_formulation B_2 - Advanced Non-small Cell Lung Cancer, EGFR Mutation | Phase 1 / Phase 2 | Recruiting | Bayer | 430 | 2021-10-25 | 2026-10-21 |
Bayer (1)
Belgium (1) · Brazil (1) · China (1) · France (1) · Hong Kong (1) · Israel (1) · Italy (1) · Japan (1) · Netherlands (1) · Poland (1) · Portugal (1) · Singapore (1) · South Korea (1) · Spain (1) · Taiwan (1)
2023 (1)